3rd Quarter - Report

JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC

Firm
Client
Income
—
Expenses
$2,350,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

13 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Issues related to: - medical supply chains - TRIPS Waiver

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
LEIF BRIERLEY —
DAVID KAVANAUGH —
TIMOTHY SWOPE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Consumer Issues/Safety/Products CSP

Issues related to: - counterfeit healthcare goods - brand protection

LobbyistCovered position, as disclosed
LEIF BRIERLEY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Science/Technology SCI

Issues related to: - data privacy - cybersecurity - artificial intelligence

LobbyistCovered position, as disclosed
LEIF BRIERLEY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

Issues related to: - contact lens safety, peripheral artery disease, and stroke care, specifically to provisions regarding appropriations report language - appropriations for Labor Health and Human Services

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
LEIF BRIERLEY —
LARRY CAMM —
DEANA MCRAE —
TIMOTHY SWOPE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

- S 1375/HR 830, "HELP Copays Act", regarding all provisions - PL 117-169, "The Inflation Reduction Act", regarding provisions impacting drug pricing and implementation - PL 113-5 "Pandemic All Hazards Preparedness Reauthorization", regarding all provisions - S 1355/HR 2940, "PASTEUR Act", regarding all provisions - HR 3723, "Medical Device Electronic Labeling Act", regarding all provisions - HR 2748, "Contact Lens Prescription Verification Modernization Act", regarding all provisions - HR 4261, "Amputation Reduction and Compassion Act", regarding all provisions Issues related to: - obesity - biosimilars - health equity and diversity in clinical trials - myopia - ambulatory surgical services - access to sterilization capacity for medical technologies - FDA approval pathways for medical technologies - peripheral artery disease - cardiovascular health - stroke care - FDA medical device shortage reporting requirements - alternative funding programs - 340B - PBM practices - health care workforce wellbeing

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 2940 (118th), H.R. 3723 (118th), H.R. 2748 (118th), H.R. 4261 (118th), H.R. 830 (118th)

Labor Issues/Antitrust/Workplace LBR

- Issues related to diversity, equity and inclusion

LobbyistCovered position, as disclosed
LARRY CAMM —

Contacted: Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES

Veterans VET

Issues related to: - Veterans Administration and Veterans Health Administration policy for return of and reuse of reprocessed medical devices; - Veterans Administration and Veterans Health Administration policy procurement and contracting processes for medical technology

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
RILEY SWINEHART —

Contacted: HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

- S 150, "Affordable Prescriptions for Patients Act of 2023", regarding all provisions. - S 79/HR 1717, "Interagency Patent Coordination and Improvement Act of 2023", regarding all provisions - Issues related to intellectual property

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
DAVID KAVANAUGH —
TIMOTHY SWOPE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1717 (118th)

Taxation/Internal Revenue Code TAX

S. 866/H.R. 2673, "American Innovation and R&D Competitiveness Act of 2023", regarding provisions related to research & development expensing. Issues related to: - OECD proposals on global tax & implementation - R&D expensing - corporate tax provisions in TCJA

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
DAVID KAVANAUGH —
KELLY WATERS —

Contacted: HOUSE OF REPRESENTATIVES; Treasury, Dept of

Bills named: S. 866 (118th), H.R. 2673 (118th)

Pharmacy PHA

- HR 4490, "To amend the Controlled Substances Act to authorize pharmacies to deliver certain controlled substances to an administering practitioner in lieu of delivering such substances to the to the ultimate user, and for other purposes", regarding all provisions - Issues related to drug shortages.

LobbyistCovered position, as disclosed
AMY PELLEGRINO —
ABIGAIL PINKELE —
MEGHAN DRENAN STONE —
WENDY SUSSMAN —
RILEY SWINEHART —
TIMOTHY SWOPE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4490 (118th)

Environment/Superfund ENV

Issues related to - clean energy - environmental sustainability

LobbyistCovered position, as disclosed
KELLY WATERS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bankruptcy BNK

Issues related to: - Chapter 11 corporate bankruptcy process - Litigation reform

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
LARRY CAMM —
ABIGAIL PINKELE —
RILEY SWINEHART —
KELLY WATERS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Issues related to the Medicaid Drug Rebate Program

LobbyistCovered position, as disclosed
AMY PELLEGRINO —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.